DELSTRIGO

Merck Canada Inc🇨🇦 Health Canada

Approval Id: df6c2af0ec90a49a
Drug Approval Canada Name: DELSTRIGO
Product Name: DELSTRIGO
Status: Marketed
Status Date: 2018-12-10
Original Market Date: 2018-12-10
Din: 02482592
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.20
Atc Original: J05AR24 LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE
Atc Name: j 05 ar 24
Aig Number: 0360870001
Company Name: Merck Canada Inc
Company Address: 16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7

DORAVIRINE

100 MG

LAMIVUDINE

300 MG

TENOFOVIR DISOPROXIL FUMARATE

300 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

df6c2af0ec90a49a

Type

Standard